Gene · 8607
NIH grants1,304
NIH grants whose papers are about the gene, through NIH's grant-paper links.
421 to 440 of 1,304
Download this page as JSON| Grant | Title | RUVBL1 papers | Newest fiscal year |
|---|---|---|---|
| R01HL127240 | Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein. | 1 | 2022 |
| R01HL146583 | Novel genetic Insight into the molecular pathogenesis of atherosclerosis | 1 | 2022 |
| R01MH095797 | Novel Statistical methods for DNA Sequencing Data, and applications to Autism. | 1 | 2022 |
| R01NS102279 | Dysregulation of p97/VCP disease mutants in IBM and FTLD-U | 1 | 2022 |
| R03CA253193 | Co-Oncogenic Role of ECD in HER2-Driven Breast Cancer | 1 | 2022 |
| R03CA256207 | Modeling Esophageal Squamous Cell Cancer Initiation | 1 | 2022 |
| R03HL150412 | Computational Prioritization of Coding and Non-Coding Variants in Congenital Heart Disease | 1 | 2022 |
| R21AI163656 | PET imaging of viral infection | 1 | 2022 |
| R21CA252387 | PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells | 1 | 2022 |
| R21CA263381 | Dissecting drug resistance in serial uveal melanoma biopsies using integrated, multi-modal single-cell profiling and novel machine learning tools. | 1 | 2022 |
| R21HD104071 | A new animal model for investigating the invasive trophoblast lineage | 1 | 2022 |
| R33AI140439 | Identification and characterization of chromatin regulators of HIV-1 latency | 1 | 2022 |
| R35CA197262 | Molecular Biology of Oncogenic Papillomaviruses | 1 | 2022 |
| R35CA197465 | Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance | 1 | 2022 |
| R35CA200422 | Molecular Basis of KSHV oncogenesis | 1 | 2022 |
| R37GM056433 | Protein Folding in the Eukaryotic Cytosol | 1 | 2022 |
| R37MH057881 | Genetics Association in Schizophrenia and Other Disorders | 1 | 2022 |
| R56HL160639 | The vital role of T404 phosphorylation of STAT2 in post-viral bacterial pneumonia | 1 | 2022 |
| T32EB009383 | Integrative Program in Complex Biological System (ipCBS) | 1 | 2022 |
| T32GM007388 | Predoctoral Training in Genetics and Molecular Biology | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/grants?page=22